InvestorsHub Logo
Followers 0
Posts 14
Boards Moderated 0
Alias Born 12/20/2013

Re: austinmediainc post# 42111

Thursday, 10/01/2015 11:14:38 AM

Thursday, October 01, 2015 11:14:38 AM

Post# of 700965
Got this off of stocktwits

Here's the quote from the Fraunhofer Center's 2014 yearly report:

""Zudem wurden erste Patienten unter der im Jahr 2014
für das auf Dendritischen Zellen beruhenden autologen
Immuntherapeutikum DCVax®-L e

Translation: "In addition, the first patients received doses of the autologous dendritic cell vaccine DCVax, in accordance with the 2014 »Hospital Exemption« of the §4b Pharmeceutical Law."
Then on page 35 it crucially states: "DCVax for the german clinical study has been produced since August 2014, and for individual patients qualifying for Hospital Exemption due to the fact that they have failed the screening protocol for the trial, since October 2014. The wording makes it sound as though ALL patients who've failed the protocol are getting the hospital exemption.

The report further states that 'significant hiring' and 'expansion to a new 200meter square facility' has taken place to cope with demand. Yet more expansions are planned.

We know that a lot of patients fail screening due to poor immunological status. There probably are 100s of patients in the Hospital Exemption
program by now; perhaps that even explains the late fund-raising as NWBO gets reimbursed for those!! It also gives tons of extra data that could persuade the DMSB to do an unscheduled interim review, and damn the alpha spend. This is MAJOR news IMO, can't believe we've missed it. Do I get a thumbs up:)

Link: just google 'fraunhofer izi 2014'. The pdf is in german.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News